Leadership
Gary Palmer, M.D., MBA
Senior Vice President, Medical Affairs
Dr. Palmer joins Pliant as Senior Vice President of Medical Affairs with over 25 years of global leadership experience in medical affairs from biopharmaceutical companies of various sizes and stages and across multiple therapeutic areas including pulmonary medicine, immunology and neurology.
Most recently, Dr. Palmer was Senior Vice President of Global Medical Affairs Immunology & Neuroscience at Bristol Myers Squibb Co (BMS). In this role, Dr. Palmer led the Worldwide Immunology, Fibrosis and Neuroscience Medical Affairs team covering a portfolio spanning 4 globally marketed medications and more than 15 development candidates across the areas of lung fibrosis, dermatology, gastroenterology, rheumatology and neurology. Prior to BMS, Dr. Palmer was Senior Vice President for Medical Affairs at Myovant Sciences, prior to the company being acquired by Sumitomo Pharma, where, in partnership with Pfizer, he helped launch two new products. Prior to Myovant, Dr. Palmer served as Senior Vice President of U.S. Medical Affairs at Actelion, now a Janssen Pulmonology Company, as Chief Medical Officer for Neuroscience at Eisai Pharmaceuticals, Vice President for Global Development and Medical Affairs at BMS and Vice President of Medical Affairs and Managed Markets at Pfizer. Dr. Palmer earned his M.D. in Family Medicine, and a M.B.A. from the University of the Witwatersrand in Johannesburg, South Africa.Our Team
Pliant is led by a team of world-renowned fibrosis researchers and highly experienced drug developers focused on translating science into novel therapies for patients in need.